Search

everythinglearnresearchcommunity

for

Search:↓

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Baricitinib was effective in treating alopecia areata in two major trials.

Tofacitinib helped regrow hair in most patients with severe hair loss.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Hedgehog pathway inhibitors could be effective in treating melanoma.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

CD2 might be a new treatment target for patchy alopecia areata.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

Biological therapy boosts the immune system to effectively fight melanoma.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

OXTR agonists may promote hair growth and be effective for treating hair loss.

SH-340 may improve skin barrier and help treat atopic dermatitis.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

The drug combination was safe and showed promise in treating advanced tumors.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.